ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Open access · bronzeAbstract read
In one paragraph
Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.
- Global trends in research of pseudomyxoma peritonei: a bibliometric and visualization analysis.Frontiers in oncology · 2024Pooled it
- An unusual colo-ovarian fistula of advanced colorectal carcinoma: A case report and literature review.Molecular and clinical oncology · 2026Article
- DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.Cell reports. Medicine · 2026Article
- Malignant transformation of mature ovarian teratoma into goblet cell adenocarcinoma: a case report.Gynecologic oncology reports · 2026Article
- Article
- Article
- A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma.Histopathology · 2026Article
- Spontaneous rupture of a mucinous borderline ovarian tumour in late pregnancy: a case report.Frontiers in oncology · 2026Article
- Ovarian Tumor Biomarkers: Correlation Between Tumor Type and Marker Expression, and Their Role in Guiding Therapeutic Strategies.International journal of molecular sciences · 2025Review
- Cellular origins of mucinous ovarian carcinoma.The Journal of pathology · 2025Review
- Low grade appendiceal mucinous neoplasm mimicking malignant ovarian tumor: A case report.International journal of surgery case reports · 2025Article
- How to differentiate primary mucinous ovarian tumors from ovarian metastases originating from primary appendiceal mucinous neoplasms: a review.Pathology oncology research : POR · 2025Review
- The Role ofInternational journal of women's health · 2025Article
- Molecular Pathology of Ovarian Endometrioid Carcinoma: A Review.Oncology research · 2025Review
- Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review.Oncology letters · 2024Article
- Multimodal diagnostic strategies and precision medicine in mucinous ovarian carcinoma: a comprehensive approach.Frontiers in oncology · 2024Review
- Article
- Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas.Cold Spring Harbor perspectives in medicine · 2023Review
- Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment.Heliyon · 2023Review
- Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery.Journal of ovarian research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
82 authors at 20 institutions in 8 countries.
Nicola S MeagherSchool of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-9134-2118
Linyuan WangDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
Peter F RambauDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
Maria P IntermaggioSchool of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.
David G HuntsmanBritish Columbia's Ovarian Cancer Research (OVCARE) Program, Vancouver General Hospital, BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada.
Lynne R WilkensCancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Mona A El-BahrawyDepartment of Histopathology, Imperial College London, Hammersmith Hospital, London, UK.
Roberta B NessUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kunle OdunsiDepartment of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Helen SteedDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology. Royal Alexandra Hospital, Edmonton, AB, Canada.
Esther HerpelTissue Bank of the National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Michael S AnglesioDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Bonnie ZhangBendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.
Neil LambieNSW Health Pathology. Prince of Wales Hospital, Sydney, NSW, Australia.
Anthony J SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Jan LubińskiDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Robert A VierkantDepartment of Health Science Research, Division of Biomedical Statistics and Informatics. Mayo Clinic, Rochester, MN, USA.
Ellen L GoodeDepartment of Health Science Research, Division of Epidemiology. Mayo Clinic, Rochester, MN, USA.
Usha MenonMRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.
Aleksandra Toloczko-GrabarekDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Oleg OszurekInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Sanela BilicBendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.
Aline TalhoukBritish Columbia's Ovarian Cancer Research (OVCARE) Program, Vancouver General Hospital, BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada.
Montserrat García-ClosasDivision of Cancer Epidemiology and Genetics. National Cancer Institute, Bethesda, MD, USA.
Qin WangCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Adeline TanDivision of Obstetrics and Gynaecology, Faculty of Health and Medical Sciences, University of Western Australia, Crawley, Western Australia, Australia.
Rhonda FarrellPrince of Wales Private Hospital, Randwick, NSW, Australia.
Catherine J KennedyCentre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
Mercedes Jimenez-LinanDepartment of Histopathology. Addenbrookes Hospital, Cambridge, UK.
Karin SundfeldtDepartment of Obstetrics and Gynecology, Sahlgrenska Cancer Center, Inst Clinical Scienses, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
John L EtterDivision of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Janusz MenkiszakDepartment of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.
Marc T GoodmanCancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Paul KlonowskiDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
Yee LeungHistopathology Department, King Edward Memorial Hospital, Perth, Western Australia, Australia.
Stacey J WinhamDepartment of Health Science Research, Division of Biomedical Statistics and Informatics. Mayo Clinic, Rochester, MN, USA.
Kirsten B MoysichDivision of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Sabine BehrensDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tomasz KluzDepartment of Obstetrics and Gynecology, Fryderyk Chopin University Hospital No 1, Faculty of Medicine, Rzeszów University, Rzeszów, Poland.
Robert P EdwardsOvarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Jacek GronwaldDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Francesmary ModugnoDivision of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Brenda Y HernandezUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Christine ChowGenetic Pathology Evaluation Centre, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
Linda E KelemenDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Gary L KeeneyDepartment of Laboratory Medicine and Pathology, Division of Anatomic Pathology. Mayo Clinic, Rochester, MN, USA.
Michael E CarneyDepartment of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Yanina NatanzonDepartment of Health Science Research, Division of Epidemiology. Mayo Clinic, Rochester, MN, USA.
Gregory RobertsonSchool of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.
Raghwa SharmaPathology West ICPMR Westmead, Westmead Hospital, The University of Sydney, Sydney, NSW, Australia.
Simon A GaytherDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Jennifer AlsopCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Hugh LukCancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Chloe KarpinskyjGynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Ian CampbellPeter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Peter SinnDepartment of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Aleksandra Gentry-MaharajGynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Penny CoulsonDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Mitul ShahCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Martin WidschwendterGynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
Katrina TangNSW Health Pathology. Prince of Wales Hospital, Sydney, NSW, Australia.
Minouk J SchoemakerDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Jennifer M KoziakAlberta Health Services-Cancer Care, Calgary, AB, Canada.
Linda S CookUniversity of New Mexico Health Sciences Center. University of New Mexico, Albuquerque, NM, USA.
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Frances DaleyDivision of Breast Cancer Research. Institute of Cancer Research, London, UK.
Björg KristjansdottirDepartment of Obstetrics and Gynecology, Sahlgrenska Cancer Center, Inst Clinical Scienses, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Constantina MateoiuDepartment of Pathology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Melissa C LarsonDepartment of Health Science Research, Division of Biomedical Statistics and Informatics. Mayo Clinic, Rochester, MN, USA.
Paul R HarnettCentre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
Audrey JungDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Anna deFazioCentre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
Kylie L GorringePeter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Paul D P PharoahCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Parham MinooDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
Colin StewartHistopathology Department, King Edward Memorial Hospital, Perth, Western Australia, Australia.
Oliver F BatheDepartments of Surgery and Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada.
Xianyong GuiDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
Paul CohenBendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.ORCID http://orcid.org/0000-0002-4860-9232
Susan J RamusSchool of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia.
Martin KöbelDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada. Martin.Koebel@albertapubliclabs.ca.ORCID http://orcid.org/0000-0002-6615-2037
University of Calgary · CAInstitute of Cancer Research · GBMayo Clinic in Florida · USUniversity of Cambridge · GBPomeranian Medical University · PLThe University of Sydney · AUUniversity of Hawaiʻi at Mānoa · USBreast Cancer Now · GBRoswell Park Comprehensive Cancer Center · USSt John of God Subiaco Hospital · AUUNSW Sydney · AUAlberta Health Services · CABC Cancer Agency · CAGerman Cancer Research Center · DEHeidelberg University · DEKing Edward Memorial Hospital · AUNew South Wales Department of Health · AUSahlgrenska University Hospital · SEUniversity of British Columbia · CAUniversity of Pittsburgh · US
Funding
RPCI-UPCI Ovarian Cancer SPOREP50CA159981 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOYSICH, KIRSTEN B. · 2013 to 2025
$19.6MMayo Cancer Genetic Epidemiology Training ProgramR25CA092049 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M., VACHON, CELINE M · 2001 to 2018
$5.3MCancer Research UK 10119Cancer Research UK 10124Cancer Research UK 16561Cancer Research UK 22905Intramural NIH HHS Z99 CA999999NCI NIH HHS P50 CA159981NCI NIH HHS R25 CA092049
Abstract
Primary ovarian mucinous tumors can be difficult to distinguish from metastatic gastrointestinal neoplasms by histology alone. The expected immunoprofile of a suspected metastatic lower gastrointestinal tumor is CK7
Indexed as
Adenocarcinoma, MucinousAppendiceal NeoplasmsBiomarkers, TumorColorectal NeoplasmsDiagnosis, DifferentialFemaleHumansImmunohistochemistryKeratin-7Matrix Attachment Region Binding ProteinsNeoplasm MetastasisOvarian NeoplasmsSensitivity and SpecificityTranscription FactorsBiomarkers, TumorKeratin-7Matrix Attachment Region Binding ProteinsSATB2 protein, humanTranscription Factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.